相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unleashing the therapeutic potential of human kallikrein-related serine proteases
Ioannis Prassas et al.
NATURE REVIEWS DRUG DISCOVERY (2015)
Tissue kallikrein induces SH-SY5Y cell proliferation via epidermal growth factor receptor and extracellular signal-regulated kinase1/2 pathway
Zhengyu Lu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
Putative kallikrein substrates and their (patho) biological functions
Yijing Yu et al.
BIOLOGICAL CHEMISTRY (2014)
Growth and survival of lung cancer cells: regulation by kallikrein-related peptidase 6 via activation of proteinase-activated receptor 2 and the epidermal growth factor receptor
Noemie Michel et al.
BIOLOGICAL CHEMISTRY (2014)
The role of kinin receptors in cancer and therapeutic opportunities
Patricia L. N. da Costa et al.
CANCER LETTERS (2014)
Mechanisms of Resistance to Intermittent Androgen Deprivation in Patients with Prostate Cancer Identified by a Novel Computational Method
Jason D. Morken et al.
CANCER RESEARCH (2014)
Metastasis of ovarian cancer is mediated by kallikrein related peptidases
Ying Dong et al.
CLINICAL & EXPERIMENTAL METASTASIS (2014)
Angiogenesis stimulated by human kallikrein-related peptidase 12 acting via a platelet-derived growth factor B-dependent paracrine pathway
Thomas Kryza et al.
FASEB JOURNAL (2014)
Protease-activated receptor-2 activates NQO-1 via Nrf2 stabilization in keratinocytes
Ji Young Kim et al.
JOURNAL OF DERMATOLOGICAL SCIENCE (2014)
Human kallikrein 2 (KLK2) promotes prostate cancer cell growth via function as a modulator to promote the ARA70-enhanced androgen receptor transactivation
Zhiqun Shang et al.
TUMOR BIOLOGY (2014)
The KLK5 protease suppresses breast cancer by repressing the mevalonate pathway
Georgios Pampalakis et al.
ONCOTARGET (2014)
Pro-angiogenic effect of human kallikrein-related peptidase 12 (KLK12) in lung endothelial cells does not depend on kinin-mediated activation of B2 receptor
Thomas Kryza et al.
BIOLOGICAL CHEMISTRY (2013)
Hypoxia enhances the expression of prostate-specific antigen by modifying the quantity and catalytic activity of Jumonji C domain-containing histone demethylases
Ho-Youl Lee et al.
CARCINOGENESIS (2013)
Vaspin inhibits kallikrein 7 by serpin mechanism
John T. Heiker et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2013)
Prostate immunotherapy: should all guns be aimed at the prostate-specific antigen?
Dev Karan
IMMUNOTHERAPY (2013)
The Impaired Viability of Prostate Cancer Cell Lines by the Recombinant Plant Kallikrein Inhibitor
Joana Gasperazzo Ferreira et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Induction of Complement C3a Receptor Responses by Kallikrein-Related Peptidase 14
Katerina Oikonomopoulou et al.
JOURNAL OF IMMUNOLOGY (2013)
Tissue kallikrein-modified human endothelial progenitor cell implantation improves cardiac function via enhanced activation of akt and increased angiogenesis
Yuyu Yao et al.
LABORATORY INVESTIGATION (2013)
Clinical significance and novel mechanism of action of kallikrein 6 in glioblastoma
Kristen L. Drucker et al.
NEURO-ONCOLOGY (2013)
Paclitaxel Resistance and Multicellular Spheroid Formation Are Induced by Kallikrein-Related Peptidase 4 in Serous Ovarian Cancer Cells in an Ascites Mimicking Microenvironment
Ying Dong et al.
PLOS ONE (2013)
Molecular circuit involving KLK4 integrates androgen and mTOR signaling in prostate cancer
Yang Jin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Telomerase and the search for the end of cancer
Simone Mocellin et al.
TRENDS IN MOLECULAR MEDICINE (2013)
Human kallikrein 4 signal peptide induces cytotoxic T cell responses in healthy donors and prostate cancer patients
Ray Wilkinson et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Anti-angiogenesis therapy in cancer: Current challenges and future perspectives
Farbod Shojaei
CANCER LETTERS (2012)
Combined expression of KLK4, KLK5, KLK6, and KLK7 by ovarian cancer cells leads to decreased adhesion and paclitaxel-induced chemoresistance
Daniela Loessner et al.
GYNECOLOGIC ONCOLOGY (2012)
Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells
Luana Schito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
PSA regulates androgen receptor expression in prostate cancer cells
Parmita Saxena et al.
PROSTATE (2012)
Targeting the kallikrein-related peptidases for drug development
Georgia Sotiropoulou et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2012)
Kallikrein-Related Peptidase 14 Acts on Proteinase-Activated Receptor 2 to Induce Signaling Pathway in Colon Cancer Cells
Valerie Gratio et al.
AMERICAN JOURNAL OF PATHOLOGY (2011)
Impact of expression differences of kallikrein-related peptidases and of uPA and PAI-1 between primary tumor and omentum metastasis in advanced ovarian cancer
J. Dorn et al.
ANNALS OF ONCOLOGY (2011)
Cleaved High-Molecular-Weight Kininogen Accelerates the Onset of Endothelial Progenitor Cell Senescence by Induction of Reactive Oxygen Species
Jihong Dai et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2011)
Androgen stimulates glycolysis for de novo lipid synthesis by increasing the activities of hexokinase 2 and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2 in prostate cancer cells
Jong-Seok Moon et al.
BIOCHEMICAL JOURNAL (2011)
Proteolytic action of kallikrein-related peptidase 7 produces unique active matrix metalloproteinase-9 lacking the C-terminal hemopexin domains
Vishnu C. Ramani et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Dual antigen target-based immunotherapy for prostate cancer eliminates the growth of established tumors in mice
Dev Karan et al.
IMMUNOTHERAPY (2011)
Kallikrein-related Peptidase 12 Hydrolyzes Matricellular Proteins of the CCN Family and Modifies Interactions of CCN1 and CCN5 with Growth Factors
Audrey Guillon-Munos et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Expression and Function of the Kallikrein-Related Peptidase 6 in the Human Melanoma Microenvironment
Stefanie Krenzer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2011)
Prostate-Specific Antigen Gene Expression and Telomerase Activity in Breast Cancer Patients: Possible Relationship to Steroid Hormone Receptors
A. Mohajeri et al.
ONCOLOGY RESEARCH (2011)
Kallikreins 5, 6 and 10 Differentially Alter Pathophysiology and Overall Survival in an Ovarian Cancer Xenograft Model
David Pepin et al.
PLOS ONE (2011)
Galectin-3 Is a Substrate for Prostate Specific Antigen (PSA) in Human Seminal Plasma
Sarika Saraswati et al.
PROSTATE (2011)
PSA affects prostate cancer cell invasion in vitro and induces an osteoblastic phenotype in bone in vivo
A. P. Cumming et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Telomeric and extra-telomeric roles for telomerase and the telomere-binding proteins
Paula Martinez et al.
NATURE REVIEWS CANCER (2011)
Kallikrein-Related Peptidase 4 A New Activator of the Aberrantly Expressed Protease-Activated Receptor 1 in Colon Cancer Cells
Valerie Gratio et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Kallikrein-related peptidase genes as promising biomarkers for prognosis and monitoring of human malignancies
Margaritis Avgeris et al.
BIOLOGICAL CHEMISTRY (2010)
Kallikrein-related peptidases: bridges between immune functions and extracellular matrix degradation
Georgia Sotiropoulou et al.
BIOLOGICAL CHEMISTRY (2010)
Kallikrein-Related Peptidase 7 Promotes Multicellular Aggregation via the α5β1 Integrin Pathway and Paclitaxel Chemoresistance in Serous Epithelial Ovarian Carcinoma
Ying Dong et al.
CANCER RESEARCH (2010)
Expression of platelet-derived growth factor (PDGF)-B and PDGF-receptor β is associated with lymphatic metastasis in human gastric carcinoma
Michiyo Kodama et al.
CANCER SCIENCE (2010)
Kallikrein-related peptidase-4 initiates tumor-stroma interactions in prostate cancer through protease-activated receptor-1
Wenbin Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Galectin-3 is an important mediator of VEGF- and bFGF-mediated angiogenic response
Anna I. Markowska et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2010)
Differential regulation of inducible and endothelial nitric oxide synthase by kinin B1 and B2 receptors
F. Kuhr et al.
NEUROPEPTIDES (2010)
Overexpression of C-MYC oncogene in prostate cancer predicts biochemical recurrence
D. Hawksworth et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2010)
Mechanisms by which cleaved kininogen inhibits endothelial cell differentiation and signalling
Robert W. Colman et al.
THROMBOSIS AND HAEMOSTASIS (2010)
Critical Role of Tissue Kallikrein in Vessel Formation and Maturation Implications for Therapeutic Revascularization
Oliver A. Stone et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
A Tumor-Protective Role for Human Kallikrein-Related Peptidase 6 in Breast Cancer Mediated by Inhibition of Epithelial-to-Mesenchymal Transition
Georgios Pampalakis et al.
CANCER RESEARCH (2009)
Ovarian Cancer Cell Detachment and Multicellular Aggregate Formation Are Regulated by Membrane Type 1 Matrix Metalloproteinase: A Potential Role in I.p. Metastatic Dissemination
Natalie M. Moss et al.
CANCER RESEARCH (2009)
Functional Roles of Human Kallikrein-related Peptidases
Georgia Sotiropoulou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
p53 polymorphisms: cancer implications
Catherine Whibley et al.
NATURE REVIEWS CANCER (2009)
The extracellular matrix protein fibronectin is a substrate for kallikrein 7
Vishnu C. Ramani et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Urokinase directly activates matrix metalloproteinases-9: A potential role in glioblastoma invasion
Yunge Zhao et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Expression of tissue and plasma kallikreins and kinin B1 and B2 receptors in lung cancer
Jessica Chee et al.
BIOLOGICAL CHEMISTRY (2008)
Tissue prostate-specific antigen facilitates refractory prostate tumor progression via enhancing ARA70-regulated androgen receptor transactivation
Yuanjie Niu et al.
CANCER RESEARCH (2008)
Lessons learnt from assembling screening libraries for drug discovery for neglected diseases
Ruth Brenk et al.
CHEMMEDCHEM (2008)
Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs)
Andrew J. Ramsay et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Prostate-specific kallikreins-2 and-4 enhance the proliferation of DU-145 prostate cancer cells through protease-activated receptors-1 and-2
Gregory J. Mize et al.
MOLECULAR CANCER RESEARCH (2008)
MMPs as therapeutic targets - Still a viable option?
Barbara Fingleton
SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY (2008)
Influence of the kallikrein-kinin system on prostate and breast tumour angiogenesis
Jadyn K. Wright et al.
TUMOR BIOLOGY (2008)
Intracellular signaling pathways regulate hormone-dependent kallikrein gene expression
Miltiadis Paliouras et al.
TUMOR BIOLOGY (2008)
Host defense peptide LL-37, in synergy with inflammatory mediator IL-1β, augments immune responses by multiple pathways
Jie Yu et al.
JOURNAL OF IMMUNOLOGY (2007)
New insights into the functional mechanisms and clinical applications of the kallikrein-related peptidase family
Nashmil Emami et al.
MOLECULAR ONCOLOGY (2007)
Kallikrein 6 induces E-cadherin shedding and promotes cell proliferation, migration, and invasion
Britta Klucky et al.
CANCER RESEARCH (2007)
Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea
Kenshi Yamasaki et al.
NATURE MEDICINE (2007)
Immunotherapy with dendritic cells for prostate cancer
Anna-Katharina Thomas-Kaskel et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Kallikrein 7 enhances pancreatic cancer cell invasion by shedding E-cadherin
Sarah K. Johnson et al.
CANCER (2007)
Kallikrein-binding protein inhibits growth of gastric carcinoma by reducing vascular endothelial growth factor production and angiogenesis
Baohe Zhu et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Mechanisms of disease: The tissue kallikrein-kinin system in hypertension and vascular remodeling
Paolo Madeddu et al.
NATURE CLINICAL PRACTICE NEPHROLOGY (2007)
Early activation of bradykinin B2 receptor aggravates reactive oxygen species generation and renal damage in ischemia/reperfusion injury
Wen-Chih Chiang et al.
FREE RADICAL BIOLOGY AND MEDICINE (2006)
Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin
Kenshi Yamasaki et al.
FASEB JOURNAL (2006)
Susceptibility to metanephric apoptosis in bradykinin B2 receptor null mice via the p53-Bax pathway
Hao Fan et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2006)
Kallikrein activates bradykinin B2 receptors in absence of kininogen
D Biyashev et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2006)
Regulation of angiogenesis by the kallikrein-kinin system
RW Colman
CURRENT PHARMACEUTICAL DESIGN (2006)
Protein kinase C (PKC)-delta/-epsilon mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin
S Greco et al.
JOURNAL OF ENDOCRINOLOGY (2006)
The antiangiogenic tissue kallikrein pattern of endothelial cells in systemic sclerosis
B Giusti et al.
ARTHRITIS AND RHEUMATISM (2005)
Kallikrein 4 (hK4) and prostate-specific antigen (PSA) are associated with the loss of E-cadherin and an epithelial-mesenchymal transition (EMT)-like effect in prostate cancer cells
TL Veveris-Lowe et al.
ENDOCRINE-RELATED CANCER (2005)
Up-regulation of gene expression by hypoxia is mediated predominantly by hypoxia-inducible factor 1 (HIF-1)
AE Greijer et al.
JOURNAL OF PATHOLOGY (2005)
Biochemical and enzymatic characterization of human kallikrein 5 (hK5), a novel serine protease potentially involved in cancer progression
IP Michael et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Two faces of high-molecular-weight kininogen (HK) in angiogenesis: bradykinin turns it on and cleaved HK (HKa) turns it off
YL Guo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
Prostate-specific antigen modulates the expression of genes involved in prostate tumor growth
B Bindukumar et al.
NEOPLASIA (2005)
Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine
AK Roos et al.
PROSTATE (2005)
Downregulation of human kallikrein 10 (KLK10/NES1) by CpG island hypermethylation in breast, ovarian and prostate cancers
M Sidiropoulos et al.
TUMOR BIOLOGY (2005)
Substrates of the prostate-specific serine protease prostase/KLK4 defined by positional-scanning peptide libraries
M Matsumura et al.
PROSTATE (2005)
The normal epithelial cell-specific 1 (NES1) gene, a candidate tumor suppressor gene on chromosome 19q13.3-4, is downregulated by hypermethylation in acute lymphoblastic leukemia
J Roman-Gomez et al.
LEUKEMIA (2004)
Virtual screening of chemical libraries
BK Shoichet
NATURE (2004)
The emerging roles of human tissue kallikreins in cancer
CA Borgoño et al.
NATURE REVIEWS CANCER (2004)
Human kallikrein 13 involvement in extracellular matrix degradation
C Kapadia et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Human kallikrein 6 degrades extracellular matrix proteins and may enhance the metastatic potential of tumour cells
MC Ghosh et al.
TUMOR BIOLOGY (2004)
Role of hyaluronan and reactive oxygen species in tissue kallikrein-mediated epidermal growth factor receptor activation in human airways
SM Casalino-Matsuda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The urokinase plasminogen activator system in cancer: Recent advances and implication for prognosis and therapy
N Sidenius et al.
CANCER AND METASTASIS REVIEWS (2003)
Ligand-dependent inhibition of β-catenin/TCF signaling by androgen receptor
DR Chesire et al.
ONCOGENE (2002)
Identification of naturally processed CD4 T cell epitopes from the prostate-specific antigen kallikrein 4 using peptide-based in vitro stimulation
JA Hural et al.
JOURNAL OF IMMUNOLOGY (2002)
Epithelial-mesenchymal transitions in tumour progression
JP Thiery
NATURE REVIEWS CANCER (2002)
Characterization of hK4 (prostase), a prostate-specific serine protease: Activation of the precursor of prostate specific antigen (pro-PSA) and single-chain urokinase-type plasminogen activator and degradation of prostatic acid phosphatase
TK Takayama et al.
BIOCHEMISTRY (2001)
Immune-mediated eradication of tumors through the blockade of transforming growth factor-β signaling in T cells
L Gorelik et al.
NATURE MEDICINE (2001)
TGF-β signaling in tumor suppression and cancer progression
R Derynck et al.
NATURE GENETICS (2001)
Increased epidermal tumors and increased skin wound healing in transgenic mice overexpressing the catalytic subunit of telomerase, mTERT, in basal keratinocytes
E González-Suárez et al.
EMBO JOURNAL (2001)
Metabolism-resistant bradykinin antagonists: Development and applications
JM Stewart et al.
BIOLOGICAL CHEMISTRY (2001)
Transforming growth factor-beta 1 mediates epithelial to mesenchymal transdifferentiation through a RhoA-dependent mechanism
NA Bhowmick et al.
MOLECULAR BIOLOGY OF THE CELL (2001)
Telomerase-deficient mice with short telomeres are resistant to skin tumorigenesis
E González-Suárez et al.
NATURE GENETICS (2000)
Unraveling the role of proteases in cancer
JE Koblinski et al.
CLINICA CHIMICA ACTA (2000)
分享论文
